Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.1075762
10.1126/science.1075762 · External reference
10.1242/jcs.147553
10.1242/jcs.147553 · External reference
10.1242/dev.091744
10.1242/dev.091744 · External reference
10.1038/35096019
10.1038/35096019 · External reference
Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation
10.1073/pnas.96.20.11156 · 1999 · External reference
10.1111/j.1471-4159.2005.03233.x
10.1111/j.1471-4159.2005.03233.x · External reference
10.1073/pnas.0510405103
10.1073/pnas.0510405103 · External reference
10.1111/j.1474-9726.2009.00536.x
10.1111/j.1474-9726.2009.00536.x · External reference
10.1016/s0896-6273(03)00627-5
10.1016/s0896-6273(03)00627-5 · External reference
10.1016/j.neuron.2008.02.024
10.1016/j.neuron.2008.02.024 · External reference
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
10.1073/pnas.2232515100 · 2003 · External reference
10.1038/ncb2217
10.1038/ncb2217 · External reference
10.1523/jneurosci.3237-08.2008
10.1523/jneurosci.3237-08.2008 · External reference
10.1007/s12035-017-0828-4
10.1007/s12035-017-0828-4 · External reference
10.1523/jneurosci.3637-10.2010
10.1523/jneurosci.3637-10.2010 · External reference
Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death
2012 · External reference
The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats
10.1016/j.neuroscience.2015.01.054 · 2015 · External reference
10.1002/glia.20816
10.1002/glia.20816 · External reference
10.1158/1535-7163.mct-10-0324
10.1158/1535-7163.mct-10-0324 · External reference
Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo
10.1523/jneurosci.3593-12.2013 · 2013 · External reference
TFP5 peptide, derived from Cdk5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke
10.1038/srep40013 · 2017 · External reference
Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
10.1016/j.bmc.2010.01.042 · 2010 · External reference
10.1523/jneurosci.0621-17.2017
10.1523/jneurosci.0621-17.2017 · External reference
10.1016/j.neuropharm.2017.10.015
10.1016/j.neuropharm.2017.10.015 · External reference
Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death
10.1038/cdd.2015.103 · 2015 · External reference
10.1021/jm049323m
10.1021/jm049323m · External reference
A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors
10.1371/journal.pone.0063030 · 2013 · External reference
Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships
10.1021/ci00020a020 · 1994 · External reference
Generation of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitors
10.3390/molecules171213740 · 2012 · External reference
History and evolution of the pharmacophore concept in computer-aided drug design
10.2174/1568026023392940 · 2002 · External reference
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
10.1038/s41598-018-33354-6 · 2018 · External reference
10.1007/s12272-015-0607-6
10.1007/s12272-015-0607-6 · External reference
10.1111/j.1747-0285.2012.01339.x
10.1111/j.1747-0285.2012.01339.x · External reference
New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro
10.1038/s41598-017-11302-0 · 2017 · External reference
Structure-based drug designing recommends HDAC6 inhibitors to attenuate microtubule-associated Tau-pathogenesis
10.1021/acschemneuro.8b00405 · 2019 · External reference
Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development
10.1016/j.compbiolchem.2017.01.004 · 2017 · External reference
10.1080/07391102.2017.1288659
10.1080/07391102.2017.1288659 · External reference
Improved protein-ligand docking using GOLD
10.1002/prot.10465 · 2003 · External reference
10.1021/ci500081m
10.1021/ci500081m · External reference
10.1093/bioinformatics/btt055
10.1093/bioinformatics/btt055 · External reference
10.1002/jcc.21816
10.1002/jcc.21816 · External reference
10.1063/1.328693
10.1063/1.328693 · External reference
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · External reference
10.1021/ja9039373
10.1021/ja9039373 · External reference
10.1021/ci500020m
10.1021/ci500020m · External reference
Crystal molecular dynamics simulations to speed up MM/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N
10.1002/jcc.21683 · 2011 · External reference
Receptor-ligand molecular docking
10.1007/s12551-013-0130-2 · 2014 · External reference
10.1038/sj.embor.7401160
10.1038/sj.embor.7401160 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1038/45159
10.1038/45159 · External reference
10.1016/s0896-6273(03)00259-9
10.1016/s0896-6273(03)00259-9 · External reference
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
10.1073/pnas.040577797 · 1999 · External reference
Novel transforming growth factor-beta receptor 1 antagonists through a pharmacophore-based virtual screening approach
10.3390/molecules23112824 · 2018 · External reference
Defining Cdk5 ligand chemical space with small molecule inhibitors of Tau phosphorylation
2005 · External reference
Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors
10.1016/j.bmcl.2012.07.068 · 2012 · External reference
10.1016/s0169-409x(02)00004-2
10.1016/s0169-409x(02)00004-2 · External reference
10.3390/jcm7120563
10.3390/jcm7120563 · External reference
